Titelia

Fund shareholders of Kyntra Bio Inc

ISIN US31572Q8814 · United States · LEI 549300Q914ULWWY95822

Fund shareholders
9
Of which ETFs
0 9 other funds
Value held
1.3M $
Share of capital
4.8 % of 4M shares on Jul 31, 2026
FundSharesValueWeight in fundShare of capital
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS 114,179774.1K $2.82 %as of Mar 31, 2026
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS 42,428287.7K $0.00 %1.05 %as of Mar 31, 2026
Fidelity Extended Market Index Fund Fidelity Concord Street Trust 21,198146.9K $0.00 %0.52 %as of Feb 28, 2026
Fidelity Total Market Index Fund Fidelity Concord Street Trust 7,00548.5K $0.17 %as of Feb 28, 2026
Fidelity Series Total Market Index Fund Fidelity Concord Street Trust 5,74439.8K $0.14 %as of Feb 28, 2026
VANGUARD CAPITAL OPPORTUNITY FUND VANGUARD HORIZON FUNDS 2,71618.4K $0.00 %0.07 %as of Mar 31, 2026
Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust 1,99113.8K $0.00 %0.05 %as of Feb 28, 2026
Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds 1851.3K $0.00 %as of Mar 31, 2026
Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III 21147.3 $0.00 %as of Apr 30, 2026

Download this table: CSV, JSON

Report an error

The funds most exposed to it

The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.

FundWeight in fund
Fidelity Extended Market Index Fund Fidelity Concord Street Trust 0.00 %as of Feb 28, 2026
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS 0.00 %as of Mar 31, 2026
Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust 0.00 %as of Feb 28, 2026
VANGUARD CAPITAL OPPORTUNITY FUND VANGUARD HORIZON FUNDS 0.00 %as of Mar 31, 2026

Quarter after quarter

Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.

QuarterShareholdersChangeSharesChange
2026Q290195,467-0.3 %
2026Q19-1195,974-18.8 %
2025Q410+1241,266-1.5 %
2025Q39244,830

Institutional managers

28 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.

ManagerSharesValue
ARMISTICE CAPITAL, LLC400,0002.7M $as of Mar 31, 2026
ACADIAN ASSET MANAGEMENT LLC105,585714 $as of Mar 31, 2026
BlackRock, Inc.84,331571.8K $as of Mar 31, 2026
TWO SIGMA INVESTMENTS, LP49,511335.7K $as of Mar 31, 2026
GEODE CAPITAL MANAGEMENT, LLC45,998311.9K $as of Mar 31, 2026
HighTower Advisors, LLC39,744269.5K $as of Mar 31, 2026
UBS Group AG27,591187.1K $as of Mar 31, 2026
RENAISSANCE TECHNOLOGIES LLC27,481186.3K $as of Mar 31, 2026
Birchview Capital, LP22,566153K $as of Mar 31, 2026
STATE STREET CORP20,284137.5K $as of Mar 31, 2026
JANE STREET GROUP, LLC12,22882.9K $as of Mar 31, 2026
ADAR1 Capital Management, LLC10,46971K $as of Mar 31, 2026
GROUP ONE TRADING LLC4,49230.5K $as of Mar 31, 2026
Axiom Investment Management LLC7044.8K $as of Mar 31, 2026
MORGAN STANLEY4883.3K $as of Mar 31, 2026
Tower Research Capital LLC (TRC)3322.3K $as of Mar 31, 2026
HARBOUR INVESTMENTS, INC.2001.4K $as of Mar 31, 2026
NATIONAL BANK OF CANADA /FI/1931.3K $as of Mar 31, 2026
OSAIC HOLDINGS, INC.1801.2K $as of Mar 31, 2026
SBI Securities Co., Ltd.1521K $as of Mar 31, 2026
ROYAL BANK OF CANADA1321K $as of Mar 31, 2026
BNP PARIBAS FINANCIAL MARKETS50339 $as of Mar 31, 2026
CWM, LLC26176 $as of Mar 31, 2026
JPMORGAN CHASE & CO1278 $as of Mar 31, 2026
CFG Wealth Management Services, Inc.320 $as of Mar 31, 2026

Declared shareholders of Kyntra Bio Inc

There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.

ShareholderDeclared stakeShares
Armistice Capital, LLC and 1 other9.88 %400,000as of Mar 31, 2026 · SCHEDULE 13G
Cite this page

Titelia. "Fund shareholders of Kyntra Bio Inc". https://titelia.com/en/stocks/kyntra-bio-inc-US31572Q8814